Resultados de la búsqueda 601-610 of 9553 for problematic

  1. Ensayos clínicos - Neurología

    The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...

  2. Neurología - Ensayos clínicos

    The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, and evaluate it to ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic ...

  4. Ensayos clínicos - Neurología

    Intracranial EEG data will be collected intraoperatively and postoperatively during routine clinical monitoring, and will be analyzed by researchers for ...

  5. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.

  6. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies. Female Patients And Female Partners Of Patients With ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ...

  8. Ensayos clínicos - Dermatología

    The purpose of this study is to evaluate how children and young adults perceive their midline sternotomy scars (in terms of appearance, associated symptoms, ...

  9. Oncología (médica) - Ensayos clínicos

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  10. Oncología (médica) - Ensayos clínicos

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...